Acurion: Valuation, Funding & Investors
Acurion is a precision oncology technology company that develops the OncoGaze™ platform for AI-driven cancer biomarker detection. The company focuses on applying advanced computational methods to analyze biomedical data and support clinical decision-making and diagnostic workflows in oncology.
Leadership & Board
- Current Number of Employees
- 16
- Current LinkedIn Followers
- 805
Latest Estimated Valuation
- Total Amount Raised
- $4M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $4M
- Latest Funding Round
- Seed Round
Employee Trend
Acurion had 16 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Acurion had 805 followers as of November 16, 2026. The number of followers increased by 5 (0.63%) week-over-week.
805Latest Followers Count
5(0.62%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 02, 2026 | Seed Round | $4.30M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| TK Partners | Seed Round |
Similar Companies
A snapshot of private companies similar to Acurion, helping you discover and navigate related company profiles.
Related News and Analysis







